What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Cancer
Hui Wang focuses on Cancer research, Cancer, Pharmacology, In vivo and Internal medicine.
His research in Cancer research intersects with topics in Cell growth, Cell cycle, Oncogene, Mdm2 and Metastasis.
His work in Cancer covers topics such as Oligonucleotide which are related to areas like Molecular biology and CpG site.
His Pharmacology research is multidisciplinary, incorporating perspectives in Carboplatin, Chemosensitizer, Cytotoxicity, Biochemistry and Gemcitabine.
Hui Wang studied In vivo and Apoptosis that intersect with Cell culture and Lung cancer.
His Internal medicine study combines topics from a wide range of disciplines, such as Endocrinology, Surgery and Oncology.
His most cited work include:
- A graphene quantum dot photodynamic therapy agent with high singlet oxygen generation (711 citations)
- Wnt/beta-catenin signaling pathway as a novel cancer drug target. (261 citations)
- Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action. (254 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Cancer research, Cell biology, Cancer and Immunology.
His biological study spans a wide range of topics, including Gastroenterology, Endocrinology and Oncology.
His research integrates issues of Cell growth, Downregulation and upregulation, Oncogene, Metastasis and In vivo in his study of Cancer research.
His In vivo study integrates concerns from other disciplines, such as In vitro and Pharmacology.
He most often published in these fields:
- Internal medicine (15.64%)
- Cancer research (13.36%)
- Cell biology (7.57%)
What were the highlights of his more recent work (between 2019-2021)?
- Cancer research (13.36%)
- Internal medicine (15.64%)
- Catalysis (3.99%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Cancer research, Internal medicine, Catalysis, Chemical engineering and Cell biology.
His Cancer research research integrates issues from Downregulation and upregulation, Metastasis and In vivo.
His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology and Oncology.
His research in Gastroenterology is mostly focused on Cirrhosis.
He does research in Catalysis, focusing on Selectivity specifically.
Between 2019 and 2021, his most popular works were:
- A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids. (167 citations)
- A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids. (167 citations)
- COVID-19: A Call for Physical Scientists and Engineers. (65 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Enzyme
Hui Wang mainly investigates Cancer research, Induced pluripotent stem cell, Organoid, Metastasis and Internal medicine.
His Cancer research study focuses on Hepatocellular carcinoma in particular.
The study incorporates disciplines such as Cell culture, Immunology, Chemokine and Fetus, Amnion in addition to Induced pluripotent stem cell.
His Organoid research includes themes of Nanotechnology, Insulin secretion, Virus, Stem cell and Droplet microfluidics.
His study explores the link between Metastasis and topics such as Immune system that cross with problems in Autocrine signalling, Paracrine signalling, Microvesicles, Reprogramming and Primary liver cancer.
His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Bioavailability and Oncology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
